These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 33075645)

  • 1. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
    Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
    Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
    Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J
    Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DKB114, A Mixture of
    Lee YS; Kim SH; Yuk HJ; Kim DS
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
    [No Abstract]   [Full Text] [Related]  

  • 4. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
    Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
    Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
    Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
    Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid.
    Jiao L; Wang R; Dong Y; Su J; Yu J; Yan M; Chen S; Lv G
    J Ethnopharmacol; 2024 Oct; 333():118488. PubMed ID: 38925319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin.
    Ota-Kontani A; Hirata H; Ogura M; Tsuchiya Y; Harada-Shiba M
    Biochem Biophys Res Commun; 2020 Jan; 521(4):861-867. PubMed ID: 31711647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1.
    Oh DR; Kim JR; Choi CY; Choi CH; Na CS; Kang BY; Kim SJ; Kim YR
    BMC Complement Altern Med; 2019 Jan; 19(1):10. PubMed ID: 30621705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3.
    Yong T; Liang D; Chen S; Xiao C; Gao X; Wu Q; Xie Y; Huang L; Hu H; Li X; Liu Y; Cai M
    Phytomedicine; 2022 Aug; 103():154256. PubMed ID: 35714456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
    Zhao ZA; Jiang Y; Chen YY; Wu T; Lan QS; Li YM; Li L; Yang Y; Lin CT; Cao Y; Zhou PZ; Guo JY; Tian YX; Pang JX
    Acta Pharmacol Sin; 2022 Jan; 43(1):121-132. PubMed ID: 33767379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.
    Hu Q; Zhou M; Zhu H; Lu G; Zheng D; Li H; Hao K
    Biomed Pharmacother; 2017 Feb; 86():88-94. PubMed ID: 27951420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
    Chen G; Tan ML; Li KK; Leung PC; Ko CH
    J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.
    Ao GZ; Zhou MZ; Li YY; Li SN; Wang HN; Wan QW; Li HQ; Hu QH
    Bioorg Med Chem; 2017 Jan; 25(1):166-174. PubMed ID: 28340987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Macroporous Resin Extract of Dendrobium officinale Leaves in Rats with Hyperuricemia Induced by Fructose and Potassium Oxonate.
    Wang YZ; Zhou C; Zhu LJ; He XL; Li LZ; Zheng X; Xu WF; Dong YJ; Li B; Yu QX; Lv GY; Chen SH
    Comb Chem High Throughput Screen; 2022; 25(8):1294-1303. PubMed ID: 34053424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia.
    Zhang Y; Jin L; Liu J; Wang W; Yu H; Li J; Chen Q; Wang T
    J Ethnopharmacol; 2018 Mar; 214():29-36. PubMed ID: 29233733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hyperuricemic effect of Alpinia oxyphylla seed extract by enhancing uric acid excretion in the kidney.
    Lee YS; Sung YY; Yuk HJ; Son E; Lee S; Kim JS; Kim DS
    Phytomedicine; 2019 Sep; 62():152975. PubMed ID: 31181404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Chuanhu anti-gout mixture, a traditional Chinese medicine, protects against potassium oxonate-induced hyperuricemia and renal dysfunction in mice.
    You W; Wang J; Zou Y; Che K; Hou X; Fei H; Wang Y
    J Int Med Res; 2019 May; 47(5):1927-1935. PubMed ID: 30832523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eggshell Membrane Ameliorates Hyperuricemia by Increasing Urate Excretion in Potassium Oxonate-Injected Rats.
    Sung YY; Kim DS
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.
    Zhao Z; Luo J; Liao H; Zheng F; Chen X; Luo J; Chen Y; Zhao K; Zhang S; Tian J; Wu T; Li Y; Li L; Yang Y; Lin C; Zhang Q; Tian Y; Pang J
    Bioorg Chem; 2023 Apr; 133():106405. PubMed ID: 36753966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.